TD Cowen Cuts agilon health (NYSE:AGL) Price Target to $2.00

agilon health (NYSE:AGL) had its price objective reduced by TD Cowen from $6.00 to $2.00 in a report released on Monday morning,Benzinga reports. They currently have a hold rating on the stock.

AGL has been the topic of a number of other research reports. Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 target price on shares of agilon health in a report on Wednesday, August 7th. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Evercore ISI decreased their target price on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Barclays decreased their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a report on Monday. Finally, Benchmark reaffirmed a “buy” rating and set a $9.00 target price on shares of agilon health in a report on Thursday, August 8th. Three investment analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $6.38.

agilon health Stock Performance

Shares of AGL stock opened at $1.89 on Monday. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 52 week low of $1.80 and a 52 week high of $13.76. The firm’s 50-day simple moving average is $3.18 and its two-hundred day simple moving average is $4.93.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.45 billion during the quarter, compared to the consensus estimate of $1.47 billion. During the same period last year, the firm earned ($0.06) EPS. On average, equities research analysts forecast that agilon health will post -0.35 earnings per share for the current year.

Insider Activity

In other agilon health news, CEO Steven Sell acquired 20,000 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was bought at an average price of $3.36 per share, with a total value of $67,200.00. Following the purchase, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 3.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On agilon health

Several institutional investors have recently added to or reduced their stakes in AGL. Capital International Investors boosted its position in agilon health by 84.7% during the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock valued at $123,207,000 after buying an additional 9,263,296 shares during the period. Citigroup Inc. boosted its position in agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after buying an additional 1,941,993 shares during the period. AQR Capital Management LLC boosted its position in agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock valued at $8,871,000 after buying an additional 1,316,990 shares during the period. Quantbot Technologies LP purchased a new stake in agilon health during the 3rd quarter valued at $1,742,000. Finally, Vanguard Group Inc. boosted its position in agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock valued at $176,582,000 after buying an additional 371,537 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.